122 related articles for article (PubMed ID: 12164868)
1. Cytochrome P450 2B1 mediates oxidant injury in puromycin-induced nephrotic syndrome.
Liu H; Bigler SA; Henegar JR; Baliga R
Kidney Int; 2002 Sep; 62(3):868-76. PubMed ID: 12164868
[TBL] [Abstract][Full Text] [Related]
2. Role of cytochrome P450 2B1 in puromycin aminonucleoside-induced cytotoxicity to glomerular epithelial cells.
Liu H; Baliga M; Bigler SA; Baliga R
Nephron Exp Nephrol; 2003; 94(1):e17-24. PubMed ID: 12806184
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P-450 as a source of catalytic iron in minimal change nephrotic syndrome in rats.
Liu H; Shah SV; Baliga R
Am J Physiol Renal Physiol; 2001 Jan; 280(1):F88-94. PubMed ID: 11133518
[TBL] [Abstract][Full Text] [Related]
4. Ethylbenzene induces microsomal oxygen free radical generation: antibody-directed characterization of the responsible cytochrome P450 enzymes.
Serron SC; Dwivedi N; Backes WL
Toxicol Appl Pharmacol; 2000 May; 164(3):305-11. PubMed ID: 10799341
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome-P450 2B1 gene silencing attenuates puromycin aminonucleoside-induced cytotoxicity in glomerular epithelial cells.
Tian N; Arany I; Waxman DJ; Baliga R
Kidney Int; 2010 Jul; 78(2):182-90. PubMed ID: 20407477
[TBL] [Abstract][Full Text] [Related]
6. Rapid changes in cytochrome P4502E1 (CYP2E1) activity and other P450 isozymes following ethanol withdrawal in rats.
Roberts BJ; Shoaf SE; Song BJ
Biochem Pharmacol; 1995 May; 49(11):1665-73. PubMed ID: 7786308
[TBL] [Abstract][Full Text] [Related]
7. Mechanism-based inactivation of cytochromes P450 2B1 and P450 2B6 by 2-phenyl-2-(1-piperidinyl)propane.
Chun J; Kent UM; Moss RM; Sayre LM; Hollenberg PF
Drug Metab Dispos; 2000 Aug; 28(8):905-11. PubMed ID: 10901699
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 2E1 null mice provide novel protection against cisplatin-induced nephrotoxicity and apoptosis.
Liu H; Baliga R
Kidney Int; 2003 May; 63(5):1687-96. PubMed ID: 12675844
[TBL] [Abstract][Full Text] [Related]
9. Influence of urethane and ketamine on rat hepatic cytochrome P450 in vivo.
Meneguz A; Fortuna S; Lorenzini P; Volpe MT
Exp Toxicol Pathol; 1999 Jul; 51(4-5):392-6. PubMed ID: 10445403
[TBL] [Abstract][Full Text] [Related]
10. Effect of cytochrome P450 2E1 inhibitors on cisplatin-induced cytotoxicity to renal proximal tubular epithelial cells.
Liu H; Baliga M; Baliga R
Anticancer Res; 2002; 22(2A):863-8. PubMed ID: 12014663
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 2B1 mediates complement-dependent sublytic injury in a model of membranous nephropathy.
Liu H; Tian N; Arany I; Bigler SA; Waxman DJ; Shah SV; Baliga R
J Biol Chem; 2010 Dec; 285(52):40901-10. PubMed ID: 20947506
[TBL] [Abstract][Full Text] [Related]
12. Disorder of fatty acid metabolism in the kidney of PAN-induced nephrotic rats.
Muroya Y; Ito O; Rong R; Takashima K; Ito D; Cao P; Nakamura Y; Joh K; Kohzuki M
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1070-9. PubMed ID: 22874759
[TBL] [Abstract][Full Text] [Related]
13. Different contributions of cytochrome P450 2E1 and P450 2B1/2 to chloroform hepatotoxicity in rat.
Nakajima T; Elovaara E; Okino T; Gelboin HV; Klockars M; Riihimäki V; Aoyama T; Vainio H
Toxicol Appl Pharmacol; 1995 Aug; 133(2):215-22. PubMed ID: 7645016
[TBL] [Abstract][Full Text] [Related]
14. The environmental pollutant 1,1-dichloro-2,2-bis (p-chlorophenyl)ethylene induces rat hepatic cytochrome P450 2B and 3A expression through the constitutive androstane receptor and pregnane X receptor.
Wyde ME; Bartolucci E; Ueda A; Zhang H; Yan B; Negishi M; You L
Mol Pharmacol; 2003 Aug; 64(2):474-81. PubMed ID: 12869653
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytochrome P450 2E1 and activation of transcription factor Nrf2 are renoprotective in myoglobinuric acute kidney injury.
Wang Z; Shah SV; Liu H; Baliga R
Kidney Int; 2014 Aug; 86(2):338-49. PubMed ID: 24717297
[TBL] [Abstract][Full Text] [Related]
16. Xenobiotic-enhanced expression of cytochrome P450 2E1 and 2B1/2B2 in primary cultured rat hepatocytes.
Zangar RC; Woodcroft KJ; Kocarek TA; Novak RF
Drug Metab Dispos; 1995 Jul; 23(7):681-7. PubMed ID: 7587954
[TBL] [Abstract][Full Text] [Related]
17. Enhanced expression of the cytoskeletal-associated protein, paxillin, in experimental nephrotic syndrome.
Koukouritaki SB; Tamizuddin A; Lianos EA
J Investig Med; 1998 Aug; 46(6):284-9. PubMed ID: 9737090
[TBL] [Abstract][Full Text] [Related]
18. Role of 'catalytic' iron in an animal model of minimal change nephrotic syndrome.
Ueda N; Baliga R; Shah SV
Kidney Int; 1996 Feb; 49(2):370-3. PubMed ID: 8821819
[TBL] [Abstract][Full Text] [Related]
19. Ascorbic acid deficiency decreases hepatic cytochrome P-450, especially CYP2B1/2B2, and simultaneously induces heme oxygenase-1 gene expression in scurvy-prone ODS rats.
Kobayashi M; Hoshinaga Y; Miura N; Tokuda Y; Shigeoka S; Murai A; Horio F
Biosci Biotechnol Biochem; 2014; 78(6):1060-6. PubMed ID: 25036135
[TBL] [Abstract][Full Text] [Related]
20. The effect of dexamethasone on P450 activities in regenerating rat liver.
Tamási V; Kiss A ; Dobozy O; Falus A; Vereczkey L; Monostory K
Biochem Biophys Res Commun; 2001 Aug; 286(2):239-42. PubMed ID: 11500027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
